欧洲疾控中心:2023年欧盟/欧洲经济区（EARS-Net）抗菌药物耐药性年度流行病学报告（英文版）

In 2023, the estimated total EU incidence of meticillin-resistant Staphylococcus aureus (MRSA) bloodstream infections was 4.64 per 100 000 population (country range 0−15.5). This was 17.6% lower than in 2019 (baseline year) and 0.15 per 100 000 population lower than the 2030 target of 4.79 per 100 000 population. For the EU overall, a statistically significant decreasing trend was detected between 2019 (baseline year) and 2023. • The estimated total EU incidence of third-generation cephalosporin